Drug-cost settlement reached
Patients treated by a list of mostly doctor-administered drugs over the past 17 years may be in line for a refund, thanks to the settlement of a class-action lawsuit that alleged price inflation.
A US District Court in Massachusetts has granted preliminary approval for the settlement, which will pay $21.8 million for claims that cover about 200 drugs.
The list encompasses treatments for cancer, infections, asthma, allergies, and HIV, among other conditions, according to a statement from the law firm Hagens Berman Sobol Shapiro. Drugs named in the list include AccuNeb, Cisplatin, Lidocaine hydrochloride, and Novacaine.
Patients can receive at least $35 if they show they paid percentage copayments for the drug, the statement said. People who made the copayments or paid full price between 1991 and March 1, 2008, are eligible.